Brachytherapy and anterior segment imaging in iris melanoma

Mostrar otras versiones (1)

Ultrasound biomicroscopy (UBM) remains a potent tool in the diagnosis and characterization of uveal lesions. In the setting of malignancy, it can confirm both placement of and response to brachytherapy. We present a case of iris melanoma with aggressive BAP-1 mutation, treated successfully with I-13...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin Soo Andy, Dmytriw, Adam A., Lakosha, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Clinical Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516456/
https://www.ncbi.nlm.nih.gov/pubmed/28757700
http://dx.doi.org/10.4103/0974-620X.209107
_version_ 1783251165135241216
author Song, Jin Soo Andy
Dmytriw, Adam A.
Lakosha, Hesham
author_facet Song, Jin Soo Andy
Dmytriw, Adam A.
Lakosha, Hesham
author_sort Song, Jin Soo Andy
collection PubMed
description Ultrasound biomicroscopy (UBM) remains a potent tool in the diagnosis and characterization of uveal lesions. In the setting of malignancy, it can confirm both placement of and response to brachytherapy. We present a case of iris melanoma with aggressive BAP-1 mutation, treated successfully with I-131 brachytherapy which was both characterized and followed with UBM and thereafter discuss the current state of these modalities.
format Online
Article
Text
id pubmed-5516456
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55164562017-07-28 Brachytherapy and anterior segment imaging in iris melanoma Song, Jin Soo Andy Dmytriw, Adam A. Lakosha, Hesham Oman J Ophthalmol Clinical Image Ultrasound biomicroscopy (UBM) remains a potent tool in the diagnosis and characterization of uveal lesions. In the setting of malignancy, it can confirm both placement of and response to brachytherapy. We present a case of iris melanoma with aggressive BAP-1 mutation, treated successfully with I-131 brachytherapy which was both characterized and followed with UBM and thereafter discuss the current state of these modalities. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5516456/ /pubmed/28757700 http://dx.doi.org/10.4103/0974-620X.209107 Text en Copyright: © 2017 Oman Ophthalmic Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Clinical Image
Song, Jin Soo Andy
Dmytriw, Adam A.
Lakosha, Hesham
Brachytherapy and anterior segment imaging in iris melanoma
title Brachytherapy and anterior segment imaging in iris melanoma
title_full Brachytherapy and anterior segment imaging in iris melanoma
title_fullStr Brachytherapy and anterior segment imaging in iris melanoma
title_full_unstemmed Brachytherapy and anterior segment imaging in iris melanoma
title_short Brachytherapy and anterior segment imaging in iris melanoma
title_sort brachytherapy and anterior segment imaging in iris melanoma
topic Clinical Image
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516456/
https://www.ncbi.nlm.nih.gov/pubmed/28757700
http://dx.doi.org/10.4103/0974-620X.209107
work_keys_str_mv AT songjinsooandy brachytherapyandanteriorsegmentimaginginirismelanoma
AT dmytriwadama brachytherapyandanteriorsegmentimaginginirismelanoma
AT lakoshahesham brachytherapyandanteriorsegmentimaginginirismelanoma

Ejemplares similares